Condition: Wound, Foot · Diabetic Foot Ulcer (DFU) · Venus Leg Ulcer · Sponsor: Capsicure, LLC
CAMPR-II Trial: A multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a saline-hydrated allogeneic dual-layer amniotic membrane product or a synthetic, resorbable polymeric wound matrix to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs
This description comes directly from the study's public registry record.
Marissa Docter, RN, BSN, MD · 512-571-2966 · mdocter@capsicure.com
Always discuss trial participation with your own doctor first.
| North Park Podiatry | San Diego, California, United States | Recruiting |
| Solutions Medical Research | Coral Gables, Florida, United States | Recruiting |
| NAR Medical and Research | Miami, Florida, United States | Recruiting |
| Nova Medical Services - Research Division LLC | Miami, Florida, United States | Recruiting |
| Indiana University Health Methodist Hospital | Indianapolis, Indiana, United States | Recruiting |
| St. Louis Foot and Ankle, LLC | St Louis, Missouri, United States | Recruiting |
| Hope Vascular and Podiatry | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07701590